摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one | 57396-72-2

中文名称
——
中文别名
——
英文名称
3,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
英文别名
3,3′,7-trihydroxy-4′-methoxyflavone;3,7,3'-trihydroxy-4'-methoxyflavone;4'-O-methyl fisetin;3,7-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-chromen-4-one;3,7-Dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-chromen-4-on;3,7,3'-Trihydroxy-4'-methoxy-flavon;3,3',7-Trihydroxy-4'-methoxyflavone;3,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one
3,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one化学式
CAS
57396-72-2
化学式
C16H12O6
mdl
——
分子量
300.268
InChiKey
QVYSSMFEUBQBEU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 物理描述:
    Solid
  • 熔点:
    288°C

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    96.2
  • 氢给体数:
    3
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Kirby; White, Biochemical Journal, 1955, vol. 60, p. 582,584
    作者:Kirby、White
    DOI:——
    日期:——
  • A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION/TREATMENT OF BONE DISORDERS AND A PROCESS FOR THE PREPARATION THEREOF
    申请人:Council of Scientific and Industrial Research
    公开号:EP1993579A2
    公开(公告)日:2008-11-26
  • UTILISATION D'UNE ASSOCIATION DE DEUX COMPOSÉS POUR LE TRAITEMENT ET/OU LA PRÉVENTION DE TROUBLES OSSEUX
    申请人:Institut National de la Recherche Agronomique (INRA)
    公开号:EP2999467B1
    公开(公告)日:2020-01-08
  • Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof
    申请人:Maurya Rakesh
    公开号:US20090221690A1
    公开(公告)日:2009-09-03
    Osteoporosis is one of the major problems in our aging society. Osteoporosis results in bone fracture in older members of the population, especially in post-menopausal women. In traditional medicine, there are many natural crude drugs that have the potential for use to treat bone diseases. So far, there is no report in literature on anti-osteoporosis (bone forming) activity of Butea species. It was thought to study the anti-osteoporotic activity of this plant. Thus, the present invention provides a pharmaceutical composition from the extracts of Butea monosperma for prevention or treatment of bone disorders, process of preparation and use thereof.
  • US8466195B2
    申请人:——
    公开号:US8466195B2
    公开(公告)日:2013-06-18
查看更多